Quantitation of Apremilast in Beagle Dogs Plasma by UPLC-MS-MS and Its Application to Pharmacokinetic Studies

<div>Mean plasma concentration versus time profile of apremilast in beagle dog after its oral administration at 30 mg·day<sup>−1</sup> <i>y</i> (<i>n</i> = 12).</div>

Journal of Analytical Methods in Chemistry

fig4

Figure 4

Figure 4: Quantitation of Apremilast in Beagle Dogs Plasma by UPLC-MS-MS and Its Application to Pharmacokinetic Studies 